Featured Story | By Amirah Al Idrus It’s not a case of déjà vu. Moderna’s COVID-19 vaccine is following the footsteps of Pfizer and BioNTech’s candidate, snagging the support of an expert panel that voted in favor of its emergency use Thursday afternoon. read more |
| |
|---|
|
|  | Admescope acquired by Symeres Admescope’s high-quality and tailored ADME-Tox services complement Symeres’ medicinal chemistry and integrated drug discovery & development services. Together we can advance your projects from hit to clinic. |
Top Stories By Phil Taylor Australian biotech Mesoblast has been riding high on expectations for its COVID-19 treatment, licensed to Novartis, but fell back to Earth after it said a phase 3 trial of the cell therapy was a bust. read more By Phil Taylor The NIH has started dosing patients in new trials of antibodies from GlaxoSmithKline/Vir Biotechnology and Brii Biosciences in patients hospitalized with COVID-19—hoping to succeed where Eli Lilly’s LY-CoV555 failed a few weeks ago. read more Sponsored By: RBC Capital Markets RBC Senior Biotech Analyst Luca Issi interviews Co-Founder of Vida Ventures Arjun Goyal on passion for investing, company purpose, and emerging modalities and investor trends in today’s unique market. read more By Ben Adams San Diego biotech Janux Therapeutics has penned a major biobucks R&D pact focused on next generation T cell engager immunotherapies in cancer. read more By Ben Adams Mereo BioPharma is teaming up with Ultragenyx to work on its rare genetic bone disease drug. read more By Conor Hale Google’s life science-focused sibling company Verily has raised a mammoth $700 million investment round to help rapidly expand its commercial reach. read more By Arlene Weintraub Mount Sinai researchers studied tumor samples from a trial of Gilead’s CAR-T therapy Yescarta in non-Hodgkin lymphoma and found that patients with high levels the protein FAS had durable positive responses. In preclinical studies, drugs that dial up FAS signaling improved the killing of cancer cells by immune cells, they reported. read more By Fraiser Kansteiner Sage Therapeutics tapped Barry Greene to become CEO at the company. John Rim was named president and CEO at Samsung Biologics. NodThera hired on Donald Johns, M.D., as chief medical officer and named Katina Dorton chief financial officer. read more By Angus Liu BioNTech will supply Chinese partner Fosun Pharma 100 million doses of its COVID-19 vaccine. Samsung Biologics promoted an insider and Roche veteran as its new CEO. Japan's drug reviewers struggled to reach a conclusion on the use of Fujifilm's Avigan in COVID-19. And more. read more Resources Sponsored By: Metabolon Learn six ways metabolomics provides greater confidence, higher success rates and complements the work of your in-house teams for your drug development pipeline. Sponsored by: ZS Learn how Aerie fueled their product launches with advanced analytics. Sponsored By: Elligo Health Research® Understanding the Challenges COVID-19 Pediatric Clinical Trials Face | White Paper Sponsored By: Thermo Fisher Scientific Lack of resources to move from lab concept to the manufacture/delivery of GMP clinical supplies to patients, key milestones can be missed. Sponsored by: Cytiva Human pluripotent stem cells (PSCs) have huge potential to produce cell therapies for many clinical areas. Here we describe a controlled, automated, and defined manufacturing process to fuel demand. Sponsored by: Covance Download the whitepaper to learn how your safety organization can implement automation technologies to enable process and cost efficiencies, improve resource allocation and ensure compliance and quality. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored By: BBK Worldwide The BBK Worldwide Study Voices 2020 survey gives voice to the healthcare consumer in the wake of COVID-19 and reveals important insights for clinical trial enrollment and engagement. Sponsored By: BioAnalytix Download this eBook and Learn the Advantages of LC-MS based HCP Profiling for Development of Complex Biologics. Sponsored By: Polpharma Biologics Innovative cell lines and early process development are critical to generate a high producing cell lines alongside a USP strategy to meet high quality standards. Sponsored by: Premier Research Browse the latest learnings and insights from our clinical development professionals. Sponsored by: Rousselot This infographic describes the benefits of GelMA in various biomedical applications and how X-Pure® GelMA can help you in your developments. Sponsored By: Lonza Liquid-filled hard capsule formulations offer unique options for the manufacture and dosing of highly potent actives. Sponsored by: Aldevron Gene and cell therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations throughout development. In this document, Aldevron provides an in-depth look at preparing for plasmid manufacturing based on our years of experience. Sponsored By: Outer Edge Technology A sound Cloud Strategy provides the flexibility and tools businesses need to quickly adapt and operate securely in an ever-changing remote work environment. Learn how your company can cost-effectively empower its employees to be productive and secure while working remotely. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. Sponsored by: Catalent This eBook provides insights on key approaches and considerations for preparing your drug development program for long-term success. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Sponsored by: Outer Edge Technology Cybercriminals Are Actively Exploiting The Coronavirus Pandemic To Gain Entry To Enterprise Networks. Don’t Let Your Company Become The Next Ransomware Headline -- Make These Changes Now! Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. | 
